PREVENTING CERVICAL CANCER ACROSS THE GLOBE
Although cervical cancer is virtually 100% preventable, more than 40 million women
each year lack access to early prevention technologies due to infrastructure constraints.
Ananya Health is building a portable medical device to treat cervical pre-cancer in the highest-burden regions of the world.
OF GLOBAL HEALTH RESEARCH AND INNOVATION GOES TO SUPPORT ONLY
OF THE WORLD'S DISEASE BURDEN.
We're changing that.
Patients and doctors in the hardest-to-reach areas of the world cannot be served with the same designs as highly resourced medtech markets. They deserve products that are thoughtfully composed for their unique considerations and needs.
Ananya Health makes affordable, appropriate technologies that address the biggest issues in global health.
Why cervical cancer?
Cervical cancer is virtually entirely preventable, yet each year, 550,000 women contract the disease and 310,000 of them will die [WHO].
Pap smears and early treatment have drastically reduced incidence rates of cervical cancer in the US and Europe - so much that 90% of diagnoses occur in countries with limited access to these resources.
We have the tools to screen women for cancer early, but we don't have the tools to treat women where power is spotty and infrastructure is lacking.
That’s where Ananya Health comes in.
OF CERVICAL CANCER IS PREVENTABLE
WOMEN DIE FROM CERVICAL CANCER EACH YEAR
OF DIAGNOSES OCCUR IN LOW AND MIDDLE INCOME COUNTRIES
Our challenge is to ensure that...every woman over 30 is screened and treated for pre-cancerous lesions. To achieve that, we need innovative technologies and strategies.
Dr. Tedros Ghebreyesus
ANANYA HEALTH'S PORTABLE,
What We're Building
Cryotherapy is a method of freezing tissue so that the body can replace it with healthy cells. In the cervix, precancerous lesions are identified through visual inspection and frozen off. Unfortunately, these procedures are traditionally difficult to access because of supply chain and power issues.
Our battery-powered platform, Ala, achieves ablative temperatures while being compact and dependable, making it ideal for clinics in India, Africa, and emerging markets where cervical cancer is most prevalent.
We enable screening & treatment in a single visit, at any clinic in the world.
Traditional systems need to be plugged in, relying on a stable power grid
Portable, battery-powered system can be used by trained health workers in any setting — from mobile clinic to hospital
Requires bulky canisters of compressed gas that need to be refilled
Reliance on expensive infrastructure raises cost per procedure
Closed-system ablation removes reliance
on heavy, hard-to-find compressed gas
Enables treatment at $1-$2
per procedure — 1/10 the
cost of other gas-based cryoablation systems
Co-Founder & CEO
Co-Founder & Medical Advisor
Co-Founder & Engineer
Anu is responsible for Ananya Health’s vision, fundraising, partnerships, and product pipeline. She has a decade of experience in medical device design and public health. Anu holds a B.S. in Biomedical Engineering from Georgia Tech.
Dan supports Ananya's product and clinical strategy. He is also the CEO and Founder of Theranova, a medical device incubator. Dan holds a B.S. in Bioengineering from UPenn and an M.D./MBA from Duke University.
Julie co-develops cryo technology at Ananya, approaching every challenge with a user-focused mindset. She holds a B.S. in Bioengineering from University of California San Diego.
Chris supports Ananya Health's engineering efforts. She brings a decade of experience in medical device startups, and a passion for womens' health, to the Ananya Health team.
Dinara supports Ananya Health's finance and administrative operations. She has deep experience in finance and accounting in the private sector, nonprofits, and the UN.
Bruce works on engineering design for Ananya Health's cryoablation platform. He has held multiple senior R&D roles in the medical device industry.